Quinazolin-derived myeloperoxidase inhibitor suppresses influenza A virus-induced reactive oxygen species, pro-inflammatory mediators and improves cell survival.
Superoxide radicals and other reactive oxygen species (ROS) are implicated in influenza A virus-induced inflammation. In this in vitro study, we evaluated the effects of TG6-44, a novel quinazolin-derived myeloperoxidase-specific ROS inhibitor, on influenza A virus (A/X31) infection using THP-1 lung...
Saved in:
Main Authors: | Juan A De La Cruz, Thota Ganesh, Becky A Diebold, Weiping Cao, Amelia Hofstetter, Neetu Singh, Amrita Kumar, James McCoy, Priya Ranjan, Susan M E Smith, Suryaprakash Sambhara, J David Lambeth, Shivaprakash Gangappa |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/80b3ccda96934ff1811aa0a4c2c44104 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MYELOPEROXIDASE DEFICIENCY: SINGLE CENTER EXPERIENCE
by: Özlem ARMAN BİLİR, et al.
Published: (2021) -
New pathways for the synthesis of indolyl-containing quinazoline trifluoroacetohydrazides
by: Yu. A. Azev, et al.
Published: (2020) -
Enhanced neutrophil apoptosis accompanying myeloperoxidase release during hemodialysis
by: Taro Fukushi, et al.
Published: (2020) -
Dynamics of the Level of Myeloperoxidase and Serum Calprotectin in Local Cold Injury
by: M. I. Mikhailichenko, et al.
Published: (2020) -
SERUM MYELOPEROXIDASE, MALONDIALDEHYDE, ALPHA-SYNUCLEIN LEVELS IN PATIENTS WITH EPILEPSY
by: Fatma Şimşek, et al.
Published: (2021)